To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Patient Power Investigators are studying the cancer risks related to high and low Immunoglobulin A (IgA) levels. Andrew Kin, M.D. , hematologist and medical oncologist, and member of the Bone Marrow & Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, discussed what certain levels of IgA may indicate, including conditions other than cancer. Read the article here .
CancerNetwork Karmanos Cancer Institute experts in multiple myeloma and chronic myeloid leukemia (CML) took part in a face-off against Cleveland Clinic. Andrew Kin, M.D. , hematologist and medical oncologist, and member of the Bone Marrow and Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams (MDTs), was the team captain for Karmanos. He was joined by Craig Cole, M.D. , hematologist, member of the Hematology Oncology and Multiple Myeloma and Amyloidos...
Patient Power Abhinav Deol, M.D. , and Andrew Kin, M.D. , both hematologists and medical oncologists and members of the Bone Marrow and Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, explain the possible treatment options for multiple myeloma patients whose disease may have relapsed. Read the article here . Abhinav Deol, M.D. Andrew Kin, M.D.